What's new in <scp>WHO</scp> fifth edition – urinary tract
Éva Compérat, Mahul B. Amin, Daniel M. Berney, Ian A. Cree, Santosh Menon, H. Moch, George J. Netto, Vishal Rao, Maria Rosaria Raspollini, Mark A. Rubin, John R. Srigley, Puay Hoon Tan, Satish K. Tickoo, Samra Turajlic, Toyonori Tsuzuki
Abstract
The fifth edition of the WHO Blue Book on urological tumours, specifically in the bladder chapter, represents a refinement and update in the classification of bladder tumours building on the aggregate major changes made in previous editions. Progress in the molecular underpinnings of urothelial tumours, particularly with promising stratifiers for more precision-based treatment approaches, have been made. Special attention has been paid to burning questions in bladder pathology, such as grading, heterogeneous lesions, inverted tumours and substaging. The concept of neuroendocrine tumours will be explained precisely.